Prednisolone for Post-COVID Syndrome

Can prednisolone improve post-COVID symptoms?

Post-COVID syndrome can involve persistent fatigue, breathlessness, difficulty concentrating, anxiety, or low mood after an initial infection. A trial reported that prednisolone, a corticosteroid that reduces inflammation, gave participants a modest lift in symptoms, but that benefit did not last. The result is encouraging as a research signal, not evidence that the medicine resolves the condition.

Post-COVID symptoms vary widely, and their causes are still being studied. A treatment that may help one symptom or group of patients may not help others. The trial’s reported short duration of benefit also matters: patients and clinicians need to weigh whether any temporary improvement justifies the medicine’s risks and monitoring requirements.

What are the risks of using prednisolone for lingering symptoms?

Prednisolone is a systemic corticosteroid. Depending on dose and duration, corticosteroids can affect blood sugar, mood, sleep, blood pressure, and infection risk, among other effects. The balance of benefit and harm depends on a patient’s health, other medicines, and the treatment plan; people should not start or stop a prescribed steroid without speaking with their clinician.

A short-lived response in a trial does not show that repeated courses or longer treatment are safe or effective. For someone with ongoing symptoms, care generally starts with assessment of the specific problems, evaluation for other treatable causes, and an individualized plan. Further research will need to clarify who might benefit, which symptoms improve, how long any benefit lasts, and what risks occur.

What should patients do about persistent post-COVID symptoms?

Ongoing breathlessness, fatigue, or cognitive difficulties can interfere with daily life and may have causes that need separate evaluation. A clinician can review the timing and pattern of symptoms, consider other conditions, and discuss supportive care or referrals suited to the person’s needs. Sudden or severe breathing difficulty, chest pain, confusion, or other urgent symptoms warrant prompt medical attention.

The trial adds to a developing evidence base, but it does not provide a universal prescription. Patients can ask their care team what the study’s findings mean for their particular symptoms and whether a steroid has a role in their situation. Decisions should account for the limited reported duration of benefit and the known potential harms of corticosteroids.